AIMS: To assess a panel of antibodies on Bouin's fixed bone marrow trephine (BMT) biopsies. These biopsies are widely used in routine diagnosis of various haematological malignancies and may be the sole material available in many centres; however, information regarding the immunostaining of this material is lacking. METHODS: Biopsies were taken from 72 patients presenting with various haematological malignancies (leukaemia, 38; lymphoma, 14; multiple myeloma, 20). A panel of antibodies was assessed on Bouin's fixed BMT biopsies by the alkaline phosphatase-antialkaline phosphatase method. RESULTS: Three B (MB2, LN-2, Ki-B5) and two T cell lineage antibodies (UCHL-1, CD3-r) reliably identified lymphoid cells, while MPO-r, Leu-M1/CD15, and KP-1/CD68 recognised cells from the myeloid or histiocytic/macrophage series. ReedSternberg cells were stained by LN-2, Leu-M1, and CD30. Antibodies specific for plasma cells (VS38) 
Abstract
Aims-To assess a panel of antibodies on Bouin's fixed bone marrow trephine (BMT) biopsies. These biopsies are widely used in routine diagnosis of various haematological malignancies and may be the sole material available in many centres; however, information regarding the immunostaining of this material is lacking.
Methods-Biopsies were taken from 72 patients presenting with various haematological malignancies (leukaemia, 38; lymphoma, 14 We report experience of immunostaining Bouin's fixed BMT biopsies using a panel of the newest MoAb and PoAb.4 7 8 Labelling was assessed on common haematological neoplasms.
Material and methods Seventy two samples were obtained from patients presenting with various haematological neoplasms (table 1) : leukaemia (n = 38), lymphoma (n = 14), and multiple myeloma (n = 20). Bouin's fixed BMT biopsies from patients with non-malignant haematological disorders (n = 8) were also included. All diagnoses were based on typical features found by cytology or histology, cytogenetics, immunophenotype, biochemistry, and molecular biology using conventional methods.
Bone marrow biopsies were all placed in Bouin's fixative (copper acetate monohydrate 25 g, picric acid 40 g, distilled water 1000 ml, formalin 100 ml, acetic acid 15 ml) for no longer than 24 hours, decalcified for six hours in 7.5% nitric acid, and embedded in paraffin. Before immunostaining, each Bouin's fixed BMT biopsy was dewaxed and rehydrated. The VS38-The use of microwave heating was mandatory with this recently discovered plasma cell marker.8 Variable immunostaining of normal and malignant plasma was observed (0 to 4+). On most slides, strongly positive malignant plasma cells, observed on the border of heavily infiltrated slides (fig 1B) , coexisted with totally negative cells in the centre of the biopsy, demonstrating the variability of labelling due to the quality of the fixation (poorer in the middle of the tissue).
T CELL ASSOCIATED ANTIBODIES UCHL-1, CD3-r-Both T lineage antibodies, which are recommended for the diagnosis of T cell lymphomas in paraffin wax embedded sections,10 stained clearly normal and malig-nant T cells. Staining with UCHL-1 was usually stronger (4+ to 5+) than with CD3-r (2+ to 3+). In concert with others, we found staining of myeloid cells with UCHL-1L. 
